Abstract:A cascade catalysis system with a "core@paratroopers" structure is proposed. Hollow MnO2 (HMnO2) acts as the "core" and H‐micelle‐GOx acts as the "paratroopers". HMnO2 reacts with endogenous H2O2 to enhance GOx's catalytic efficiency for starvation therapy, reducing tumor hypoxia. This system degrades rapidly in the tumor microenvironment with high glutathione expression, releasing and penetrating the ultra‐small H‐micelle‐GOx "paratroopers" within the tumor. The catalytic therapy based on the nanozymes has received increasing interest in cancer treatment. However, the catalytic capabilities of standalone nanozymes are relatively limited, necessitating the development of a nano‐bio composite system that integrates both nanozymes and natural enzymes. This construction often inevitably leads to interference between natural enzyme and nanozymes, resulting in reduced synergistic performance. Herein, a cascade catalysis system featuring the "core@paratroopers" structure is proposed, wherein hollow manganese dioxide (HMnO2) serves as "core" and ultra‐small hybrid single‐micelle (H‐micelle) encapsulated with glucose oxidase (GOx) as "paratroopers" (H‐micelle‐GOx). The outer SiO2 layer of the H‐micelle can effectively protect the GOx. Under hypoxic conditions, HMnO2 reacts with endogenous H2O2 to produce O2, thereby enhancing the catalytic efficiency of GOx for starvation therapy. Simultaneously, the generated H2O2 boosts the catalytic efficiency of HMnO2, accelerating local O2 generation and alleviating tumor hypoxia. Additionally, this system exhibits rapid degradation in the tumor microenvironment characterized by high glutathione (GSH) expression, facilitating the release and deep penetration of the ultra‐small H‐micelle‐GOx "paratroopers" within the solid tumor.

Drug-Induced Self-Assembly Cascade Nanoreactor for Synergistic Tumor Therapy

Biomimetic Cascade Polymer Nanoreactors for Starvation and Photodynamic Cancer Therapy

Drug-induced co-assembly of albumin/catalase as smart nano-theranostics for deep intra-tumoral penetration, hypoxia relieve, and synergistic combination therapy

Multifunctional nanoreactors-integrated microneedles for cascade reaction-enhanced cancer therapy

Collagen-anchored Cascade Nanoreactors with Prolonged Intratumoral Retention for Combined Cancer Starvation and Chemotherapy

A biomimetic cascade nanoreactor for tumor targeted starvation therapy-amplified chemotherapy

Nano-Clustered Cascaded Enzymes for Targeted Tumor Starvation and Deoxygenation-Activated Chemotherapy Without Systemic Toxicity.

A Glucose/Oxygen-Exhausting Nanoreactor for Starvation- and Hypoxia-Activated Sustainable and Cascade Chemo-Chemodynamic Therapy

Cascade-reaction-triggered Engineering Nanocatalytic Theranostics Reconstructing Tumor Microenvironment Through Synergistic Oxidative Damage and Aerobic Glycolysis Inhibition Against Colon Cancer

Dual Enzyme‐Encapsulated Materials for Biological Cascade Chemistry and Synergistic Tumor Starvation

A Dual Functional Nanoreactor for Synergistic Starvation and Photodynamic Therapy

"Three‐in‐One" Nanozyme Composite for Augmented Cascade Catalytic Tumor Therapy

Engineering biomimetic ATP-responsive Se-containing core-shell cascade nanozyme for efficient tumor combination therapy

Cascade in Situ Self‐Assembly and Bioorthogonal Reaction Enable the Enrichment of Photosensitizers and Carbonic Anhydrase Inhibitors for Pretargeted Cancer Theranostics

A MXene-Based Bionic Cascaded-Enzyme Nanoreactor for Tumor Phototherapy/Enzyme Dynamic Therapy and Hypoxia-Activated Chemotherapy

Implantable Fibrous Scaffold with Hierarchical Microstructure for the ‘On-Site’ Synergistic Cancer Therapy

High-performance self-cascade nanoreactors for combined ferroptosis, photothermal therapy, and starving therapy

Biomimetic nanoreactor for targeted cancer starvation therapy and cascade amplificated chemotherapy

Coacervation-Driven Semipermeable Nanoreactors for Enzymatic Cascade-Mediated Cancer Combination Therapy with Enhanced Efficacy

Core@paratroopers Nanoassemblies with Catalytic Cascade for Efficient Tumor Starvation Therapy

Prodrug-Based Nanoreactors with Tumor-Specific <i>In Situ</i> Activation for Multisynergistic Cancer Therapy